CoChat

Inhibitors of Calmodulin-Dependent Protein Kinase Are Nonspecific Blockers of Voltage-Dependent K+ Channels in Vascular Myocytes

Ledoux, Jonathan, Chartier, Denis, Leblanc, Normand · 1999 · The Journal of Pharmacology and Experimental Therapeutics
Cited by 118

The DOI matches its Crossref record.

Abstract

The present study was undertaken to investigate the effects of specific inhibitors of calmodulin-dependent protein kinase II (CamKII) on macroscopic voltage-dependent K(+) current (K(V)) recorded from rabbit portal vein smooth muscle cells. Inhibition of L-type Ca(2+) current facilitation by 1 microM KN-62, a blocker of CamKII, was first demonstrated and provided evidence for functional CamKII activity in this preparation. KN-93, another specific and more potent inhibitor of CamKII in the rat brain, suppressed K(V) and enhanced the rate of inactivation in a dose-dependent manner, in cells dialyzed with both low (0.1 mM) and high (10 mM) EGTA pipette solution. Prolonged dialysis with 10 microM of a synthetic peptide inhibitor of CamKII (fragment 281-301) had little effect on K(V) and did not prevent the inhibitory action of KN-93 on the current. The estimated IC(50) for inhibiting peak and late currents during 250-ms steps to +60 mV (holding potential = -60 mV) were 2.9 and 0.27 microM, respectively. KN-93 also induced slight shifts of the steady-state activation (-7 mV) and inactivation (-6 mV) curves. KN-62, and KN-92, an inactive analog of KN-93, produced effects similar to those of KN-93. In current clamp experiments, 5 microM KN-93 depolarized the myocytes from a control resting membrane potential of -42.3 +/- 2.8 mV to -28.5 +/- 1.4 mV, an effect that was partially reversible after washout (-34.4 +/- 1.3 mV, n = 6). In conclusion, blockers of CamKII produce nonspecific inhibitory effects on K(V) that warrant cautious use of these compounds in physiological experiments designed to assess the role of CamKII.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0022-3565(24)35019-0

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 118

Metadata

Authors
Ledoux, J., Chartier, D., & Leblanc, N.
Venue
The Journal of Pharmacology and Experimental Therapeutics
Publisher
Elsevier BV
Published
1999-09
Volume
290
Issue
3
Pages
1165-1174
ISSN
0022-3565 (ISSN-L)
OpenAlex
W2256503736
Cited by
118
References
0
FWCI
1.52
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibitors of Calmodulin-Dependent Protein Kinase Are Nonspecific Blockers of Voltage-Dependent K+ Channels in Vascular Myocytes. https://app.cochat.ai/papers/10.1016/s0022-3565(24)35019-0
The paper
Ledoux, J., Chartier, D., & Leblanc, N. (1999). Inhibitors of Calmodulin-Dependent Protein Kinase Are Nonspecific Blockers of Voltage-Dependent K+ Channels in Vascular Myocytes. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1016/s0022-3565(24)35019-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.